References
- Reiss E. Molecular Immunology of Mycotic and Actinomycotic Infections. Elsevier, New York 1986; 11–14
- Obayashi, T, Yoshida, M, Mori, T, et al. Plasma (1 → 3)-β-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17–20
- Obayashi, T, Tamura, H, Tanaka, S, et al. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985; 149: 55–65
- Obayashi, T, Tamura, H, Tanaka, S, et al. Removal of limulus test-interfering factors in blood samples with perchloric acid and the improvement of the specificity of the limulus test by fractionating amebocyte lysate. Proc Clin Biol Res 1987; 231: 357–369
- Obayashi, T, Yoshida, M, Tamura, H, et al. Determination of plasma (1 → 3)-β-d-glucan: a new diagnostic aid to deep mycosis. J Med Vet Mycol 1992; 30: 275–280
- Obayashi T. Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: comparison with conventional procedures and clinical applications. J Lab Clin Med 1984; 104: 321–330
- Ikegami, K, Ikemura, K, Shimazu, T, et al. Early diagnosis of invasive candidiasis and rapid evaluation of antifungal therapy by combined use of conventional chromogenic limulus test and a newly developed endotoxin specific assay. J Trauma 1988; 28: 1118–1126
- Iwama, A, Yoshida, M, Miwa, A, et al. Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. Eur J Haematol 1993; 51: 156–160
- Merz, WG, Karp, JE, Hoagland, M, et al. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis 1988; 158: 1046–1055
- Anaissie, E, Bodey, GP, Kantarjian, H, et al. New spectrum of fungal infections in patients with cancer. Rev Infect Dis 1989; 11: 369–378
- Warnock DW, Johnson EM. Clinical manifestations and management of hyalohyphomycosis, phaeohyphomycosis and other uncommon forms of fungal infection in the compromised patient. Fungal Infection in the Compromised Patient2nd edn., DW Warnock, MD Richardson. John Wiley, New York 1991; 247–310, In
- Perfect JR, Schell WA, Rinaldi MG. Uncommon invasive fungal pathogens in the acquired immunodeficiency syndrome. J Med Vet Mycol 1993; 31: 175–179
- Hopwood V, Evans EGV. Serological tests in the diagnosis and prognosis of fungal infection in the compromised patient. Fungal Infection in the Compromised Patient2nd edn., DW Warnock, MD Richardson. John Wiley, New York 1991; 311–353, In
- Haynes KA, Westerneng TJ, Fell JW, Moens W. Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA. J Med Vet Mycol 1995; 33: 319–325
- Morimoto, S, Shimazaki, C, Goto, H, et al. Trichosporon cutaneum fungemia in patients with acute myeloblastic leukemia and measurement of serum d-arabinitol, Candida antigen (CAND-TEC), and β-d-glucan. Ann Hematol 1994; 68: 159–161